GSK (ADR) (GSK)
Develops specialty medicines and vaccines through immune-system science and advanced technologies.
$50.59
vs last close−0.49 (−0.96%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 16.09% | 347.23M ADS | |
|---|---|---|---|
| 1,078 holders · as of Jun 30, 2026 | |||
| Other | 83.91% | 1.81B ADS | |
| remainder | |||
2.16B ADS (1 ADS = 2 ordinary shares) as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
1,078 holders · 347.23M shares · 111 new positions · 492 increased · 346 reduced · 99 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 64.96M | 3.01% | −2.70M | Aug 13, 2026 |
| Dodge & Cox | 48.20M | 2.23% | −10.47M | Aug 13, 2026 |
| Fisher Asset Management, LLC | 35.72M | 1.66% | +1.20M | Aug 4, 2026 |
| Primecap Management Co/CA/ | 25.18M | 1.17% | −22.5K | Aug 14, 2026 |
| Wellington Management Group LLP | 11.40M | 0.53% | −321.4K | Aug 14, 2026 |
| JTC Employer Solutions Trustee Ltd | 8.59M | 0.40% | −449.4K | Jul 31, 2026 |
| Morgan Stanley | 7.66M | 0.35% | −3.37M | Aug 13, 2026 |
| Royal Bank of Canada | 7.59M | 0.35% | +82.1K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 8.90% | 369.58M | 13G | Mar 7, 2025 |
| FMR LLC | 5.80% | 234.94M | 13G | May 6, 2026 |
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.